Evaluation of Lawsonia inermis (henna) pigment as a carrier of antigens inoculated by transcutaneous immunization pigment in mice;Avaliação do pigmento de Lawsonia inermis (henna) como carreador de antígenos inoculados por via transcutânea em camundongos

Scientia Medica

Volumn 23, Issue 1, 2013, Pages 34-40

  Biffi, Karoline ^a   de Rezende, Alexandre Gonçalves ^b   de Almeida, Letícia ^c   Yajima, Caroline Kimie Brandão ^c   Barbieri, Fernanda Cinto ^d   Moreira, Marcela de Lima ^e   de Britto, Maria Cristina Lorencini ^c   Rosa, Vanessa Lopes ^c   da Silva, Ticiane Batista ^c   de Lima, Tayra Ferreira Oliveira ^c   Costa, Renata de Oliveira Santos ^c   Vasconcelos, Pedro Eduardo Nascimento Silva ^c   Coelho, Luiz Felipe Leomil ^c,f   Malaquias, Luiz Cosme Cotta ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^d Pesquisa e Desenvolvimento da Rheabiotech   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adjuvants; Antibodies; Immunoadjuvants; Immunologic; Transcutaneous administration; Vaccination

Indexed keywords

BOVINE SERUM ALBUMIN; FUNGUS ANTIBODY; FUNGUS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; NITRIC OXIDE; PIGMENT;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN FUNCTION; ARTICLE; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; IMMUNIZATION; INOCULATION; LAWSONIA INERMIS; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; SUPERNATANT; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84876806854     PISSN: 18065562     EISSN: 19806108     Source Type: Journal    
DOI: 10.15448/1980-6108.2013.1.12084     Document Type: Article

References (21)

1. Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine induced protection in humans. Virology. 2011;411:206-15.
2. Kersten G, Hirschber H. Needle-free vaccine delivery. Exp. Opin. Drug Deliv. 2007;4:459-74.
3. Denis F, Alain S, Ploy MC. New routes of administration: epidermal, transcutaneous mucosal ways of vaccination. Med Sci. 2007;23:379-85.
4. Gerdts V, Mutwiri GK, Tikoo SK, et al. Mucosal delivery of vaccines in domestic animals. Vet Res. 2006;37:487-510.
5. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005;5:617-28.
6. Glenn GM, Kenney RT, Hammond SA, et al. Transcutaneous immunization and immunostimulant strategies. Immunol Allergy Clin North Am. 2003;23:787-13.
7. Glenn GM, Flyer DC, Ellingsworth LR, et al. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Rev Vaccines. 2007;6: 809-19.
8. Guebre-Xabier M, Hammond SA, Epperson DE, et al. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol. 2003;77:5218-25.
9. Fingerut E, Gutter B, Goldway M, et al. B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination. Vet Immunol Immunopathol. 2006;112(3-4): 253-63.
10. Camargo ZP, Berzaghi R, Amaral CC, et al. Simplified method for producing Paracoccidioides brasiliensis exoantigens for use in immunodiffusion tests. Med Mycol. 2003;41:539-42.
11. Green LC, Wagner DA, Glogowski J, et al. Analyses of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131-8.
12. Glenn GM, Scharton-Kersten T, Vassell R, et al. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun. 1999;67:1100-6.
13. Belyakov IM, Hammond SA, Ahlers JD, et al. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest. 2004;113:998-07.
14. Combadière B, Vogt A, Mahé B, et al. Preferential amplification of CD8 Effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One. 2010;26;5(5):e10818.
15. Scharton-Kersten T, Yu J, Vassell R,. et al. Transcutaneous Immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect Immun. 2000;68:5306-13.
16. Glenn GM, Rao M, Matyas GR, et al. Skin immunization made possible by cholera toxin. Nature. 1998;391:851.
17. Carretero P, Garcés MM, Herrero D, et al. Contact dermatitis due to a henna tattoo. Alergol. Inmunol. Clin. 2000;15: 325-7.
18. Heckert RA, Elankumaran S, Oshop GL, et al. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol. 2002;89:67-81.
19. Pokorna D, Rubio I, Müller M. DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther. 2008;6:4.
20. Ghoreishi M, Dutz JP. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL- J Immunol. 2006;176:2635-44.
21. Naito S, Maeyama J, Mizukami T, et al. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant. Vaccine. 2007;25:8762-70.